PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-06-02

Date Title Company
02-Jun-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
02-Jun-2020 Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study Innovent Biologics, Inc.
02-Jun-2020 Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study Innovent Biologics, Inc.
02-Jun-2020 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics
02-Jun-2020 MorphoSys to Present at Upcoming Virtual Investor Conferences (news with additional features) MorphoSys AG
02-Jun-2020 Evofem Announces Proposed Public Offering of Common Stock Evofem Biosciences, Inc.
02-Jun-2020 LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant LaunchPad Medical, Inc.
02-Jun-2020 BioMatrix Expands National Footprint With Acquisition Of City Drugs Specialty Pharmacy BioMatrix Specialty Pharmacy
02-Jun-2020 RegeneRx Advisory on ARISE-3 Dry Eye Trial RegeneRx Biopharmaceuticals, Inc.
02-Jun-2020 Delta 4 Announces Results Achieved with Drug Discovery Platform B3C newswire
02-Jun-2020 Turapur Water Pitcher Reviews – Reasons to Use This Product Revealed Wired Release
02-Jun-2020 Oncoinvent Announces Result of Oversubscribed Repair Issue Oncoinvent AS
02-Jun-2020 BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020 Brainstorm Cell Therapeutics Inc
02-Jun-2020 Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome Cellenkos, Inc.
02-Jun-2020 Surgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines Intrinsic Therapeutics, Inc.
02-Jun-2020 Navenio lands Innovate UK investment to improve hospital patient care Navenio
02-Jun-2020 Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman Domainex Ltd
02-Jun-2020 Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 Gilead
02-Jun-2020 Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans Eli Lilly and Company
02-Jun-2020 PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE FOR REMIMAZOLAM IN ITALIAN HOSPITAL PAION AG